Dapagliflozin D5
| Product Name | Dapagliflozin D5 |
|---|---|
| Alternate Names | Dapagliflozin Stable Isotopes, Stable Isotopes of Dapagliflozin |
| CAT No. | CS-T-51602 |
| CAS No. | 1204219-80-6 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 413.90 g/mol |
| Mol. For. | C₂₁H₂₀D₅ClO₆ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Dapagliflozin |
| Purity | 95% |
| Therapeutic | Anti-Diabetic |
| Smileys | O[C@H]1[C@H](C2=CC(CC3=CC=C(OC([2H])([2H])C([2H])([2H])[2H])C=C3)=C(Cl)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O |
| Canonical Smiles | CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl |
| InchIKey | JVHXJTBJCFBINQ-CAXKFZQOSA-N |
| Inchl | InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1/i1D3,2D2 |
| IUPAC | (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(1,1,2,2,2-pentadeuterioethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Dapagliflozin D5 is a stable isotope labeled version of the drug dapagliflozin, which is used to treat type 2 diabetes. It works by blocking the SGLT2 protein in the kidneys, which reduces the amount of glucose that is reabsorbed into the bloodstream. This leads to increased glucose excretion in urine and lower blood sugar levels in the body.
Dapagliflozin D5 is primarily used in clinical research studies to study the pharmacokinetics, pharmacodynamics, and metabolism of dapagliflozin. The stable isotope labeling allows for accurate quantification and tracking of the drug and its metabolites in biological samples, which can provide valuable insights into drug efficacy and safety.
Chemically, dapagliflozin D5 is a sodium-glucose co-transporter 2 (SGLT2) inhibitor with a molecular formula of C21H22CIN6O5S2D5Na. Its molecular weight is 510.0 g/mol. The drug is typically administered orally as a tablet, with dosages ranging from 5-10mg per day depending on the patient's individual needs.
While dapagliflozin D5 is not commonly used in clinical practice, its use in research studies can provide important information for improving the treatment of type 2 diabetes and other related conditions.
Get an Instant Quote
Related Compounds
Dapagliflozin D4 | Dapagliflozin 13C6 | Dapagliflozin-6-13C | Dapagliflozin 3-O-β-D-Glucuronide D5 | Dapagliflozin D7 |